MOB — Moberg Pharma AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK378.45m
- SEK89.30m
- SEK9.81m
- 46
- 21
- 37
- 23
Annual cashflow statement for Moberg Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 18 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14 | -20.1 | -20.2 | -27.5 | -325 |
| Depreciation | |||||
| Non-Cash Items | -1.61 | 0.391 | 2.17 | 4.31 | 309 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31.8 | 1.85 | -1.37 | -12.2 | -2.03 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.6 | -15.3 | -16.8 | -33.2 | -16.5 |
| Other Investing Cash Flow Items | -65.9 | -41.3 | -68.1 | -124 | -73.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -65.9 | -41.3 | -68.1 | -124 | -73.6 |
| Financing Cash Flow Items | -837 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -808 | 130 | 108 | 92.3 | 323 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -890 | 73.4 | 22.9 | -65 | 233 |